Clinical Trials
3 trialsNCT05703542 2025-07-18
BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome
Dana-Farber Cancer Institute
Phase 1 Recruiting
NCT04171219 2025-05-16
Talabostat and Pembrolizumab for the Treatment of Advanced Solid Cancers
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00489710 2023-08-22
Talabostat in Treating Patients With Metastatic Kidney Cancer
University of Nebraska
Phase 2 Withdrawn